Response‐Adaptive Randomization for Clinical Trials with Continuous Outcomes

From MaRDI portal
Publication:5492099

DOI10.1111/j.1541-0420.2005.00496.xzbMath1097.62139OpenAlexW2071812934WikidataQ51934953 ScholiaQ51934953MaRDI QIDQ5492099

William F. Rosenberger, Lanju Zhang

Publication date: 12 October 2006

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1111/j.1541-0420.2005.00496.x




Related Items (30)

A simple solution to the inadequacy of asymptotic likelihood-based inference for response-adaptive clinical trials: likelihood-based inference for RAR trialsExact statistical power for response adaptive designsA new inferential approach for response-adaptive clinical trials: the variance-stabilized bootstrapEfficient randomized-adaptive designsAn optimal response-adaptive design with dual constraintsDoubly adaptive biased coin designs with heterogeneous responsesA new design strategy for hypothesis testing under response adaptive randomizationOptimal response and covariate-adaptive biased-coin designs for clinical trials with continuous multivariate or longitudinal responsesLongitudinal covariate-adjusted response-adaptive randomized designsA randomized two stage allocation for continuous response clinical trialsA comparison between two treatments in a clinical trial with an ethical allocation designCovariate-adjusted response-adaptive designs for censored survival responsesResponse-adaptive randomization in clinical trials: from myths to practical considerationsImmigrated urn models-theoretical properties and applicationsA new response-adaptive design for continuous treatment responses for phase III clinical trialsStatistical properties of two-color randomly reinforced urn design targeting fixed allocationsA sequential design for a clinical trial with a linear prognostic factorNonparametric covariate-adjusted response-adaptive design based on a functional urn modelA distribution-free approach for selecting better treatment through an ethical allocationOptimal response-adaptive allocation designs in phase III clinical trials: incorporating ethics in optimalityOn a two-treatment adaptive allocation rule for continuous responseSequential monitoring of response-adaptive randomized clinical trialsResponse-Adaptive Randomization for Survival Trials: The Parametric ApproachImplementing optimal allocation in clinical trials with multiple endpointsMulti-treatment optimal response-adaptive designs for phase III clinical trialsSequential monitoring of response-adaptive randomized clinical trials with sample size re-estimationOn optimal designs for clinical trials: an updated reviewAsymptotics in response-adaptive designs generated by a two-color, randomly reinforced urnIntermediate Monitoring, Sample Size Reassessment, and Multi-Treatment Optimal Response-Adaptive Designs for Phase III Clinical Trials with More Than One ConstraintKernel-Based Response-Adaptive Design for Continuous Responses



Cites Work




This page was built for publication: Response‐Adaptive Randomization for Clinical Trials with Continuous Outcomes